VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) reached a new 52-week high during trading on Monday. The company traded as high as $124.17 and last traded at $123.36, with a volume of 24,157 shares traded. The stock had previously closed at $122.65.
VanEck Pharmaceutical ETF Stock Up 0.4%
The firm has a market capitalization of $1.11 billion, a PE ratio of 29.81 and a beta of 0.43. The firm’s 50 day moving average price is $113.65 and its two-hundred day moving average price is $108.68.
VanEck Pharmaceutical ETF Cuts Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, October 6th. Investors of record on Thursday, October 1st were paid a dividend of $0.36 per share. This is a negative change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $1.44 annualized dividend and a yield of 1.2%.
Hedge Funds Weigh In On VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF Company Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Read More
- Five stocks we like better than VanEck Pharmaceutical ETF
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
